Blog
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
Leading medical experts and patient advocates came together last week for a Congressional Briefing hosted by American Liver Foundation (ALF) on Liver Cancer: Prevalence, Risk Factors, and Strategies for Prevention and Treatment.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
See how two celebrities brought their personal struggles with liver disease into the national spotlight last year to raise awareness around this silent killer.
American Liver Foundation (ALF) proudly announces its 50th anniversary, marking five decades of unwavering commitment to advancing liver health, empowering liver patients and their families, providing groundbreaking public health initiatives and programs, and funding close to $30 million in critical research that supports and educates the 100 million Americans living with some form of liver disease.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
ALF is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
American Liver Foundation (ALF) is thrilled to announce the recipients of its 2025 research awards totaling an historic $1.1M in funding to support early-career scientists, post-doctoral trainees and junior faculty who are providing cutting-edge research in basic, translational and clinical projects.
American Liver Foundation (ALF) is pleased to announce a new partnership with Helio Genomics (Helio) that empowers millions of Americans to find out if they are at risk for, or already have, liver cancer.
ALF is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants.